Curis Lifesciences Limited – IPO
Curis Lifesciences Limited – IPO Details
| IPO Date | November 7, 2025 to November 11, 2025 |
| Listing Date | November 14, 2025 |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 120 to ₹ 128 / Share |
| Lot Size | 1000 Shares |
| Total Issue Size | 21,50,000 shares (Aggregating up to ₹27.52 Cr) |
| Fresh Issue | |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share holding pre issue | 59,34,434 shares |
| Share holding post issue | 80,84,434 shares |
| Market Maker portion |
Curis Lifesciences Limited Timeline (Tentative Schedule)
Curis Lifesciences Limited IPO opens on November 7, 2025, and closes on November 11, 2025.
| IPO Open Date | November 7, 2025 |
| IPO Close Date | November 11, 2025 |
| Basis of Allotment | November 12, 2025 |
| Initiation of Refunds | November 13, 2025 |
| Credit of Shares to Demat | November 13, 2025 |
| Listing Date | November 14, 2025 |
| Cut-off time for UPI mandate confirmation | November 11, 2025 |
Curis Lifesciences Limited IPO Lot Size
Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | Rs.256,000 |
| Retail (Max) | 2 | 2,000 | Rs.256,000 |
| S-HNI (Min) | 3 | 3,000 | Rs.384,000 |
| S-HNI (Max) | 7 | 7,000 | Rs.896,000 |
| B-HNI (Min) | 8 | 8,000 | Rs.1,024,000 |
| HNI (Min) |
Curis Lifesciences Limited IPO Promoter Holding
| Share Holding Pre Issue | 92.68% |
| Share Holding Post Issue | 68.03% |
Curis Lifesciences Limited IPO Reservation
Curis Lifesciences IPO offers total 21,50,000 shares. Out of which 10,18,000 (47.35%) allocated to QIB, 4,08,000 (18.98%) allocated to QIB (Ex- Anchor), 3,08,000 (14.33%) allocated to NII, 7,16,000 (33.30%) allocated to RII, and 6,10,000 (28.37%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | 1,08,000 (5.02%) |
|
| Other Shares Offered | |
|
| QIB Shares Offered | 10,18,000 (47.35%) |
|
| NII (HNI) Shares Offered | 3,08,000 (14.33%) |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | 7,16,000 (33.30%) |
|
| Employee Shares Offered | |
|
| Total Shares Offered | 21,50,000 (100.00%) |
Curis Lifesciences Limited IPO Anchor Investors Details
Curis Lifesciences IPO raises ₹7.81 crore from anchor investors. Curis Lifesciences' IPO Anchor bid date is November 6, 2025.
| Bid Date | 2025-11-06 |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | 7.81 |
| Anchor lock-in period end date for 50% shares (30 Days) | December 12, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | February 10, 2026 |
About Curis Lifesciences Limited
Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products.
The company manufactures pharmaceutical products globally and domestically on a license or contract basis, as well as for its own brand marketing.
The company serves over 100 corporate clients on loan licenses or contract manufacturing, and 2 clients for its own brand marketing in Yemen and Kenya.
Products:
- General pharmaceutical tablets and capsules
- Oral liquids
- External preparations
- Sterile ophthalmic ointments
The company operates a state-of-the-art manufacturing facility in Sanand, Gujarat, adhering to stringent quality control measures to ensure product safety and efficacy.
As of July 31, 2025, the company has 95 permanent employees.
Competitive Strengths:
- Experienced Promoters and Management Team
- Wide range of Products
- Strategic Location of Manufacturing Facility
- Scalable Business Model
- Quality assurance
Key Performance Indicator
The market capitalization of Curis Lifesciences IPO is ₹103.48 Cr.
| KPI | Values |
|---|---|
| ROE | 55.25% |
| ROCE | 27.83% |
| Debt/Equity | 0.96 |
| RoNW | 37.62% |
| P/BV | 12.64 |
| PAT Margin (%) | 12.43% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 10.29 | 10.66 |
| P/E (x) | 12.44 | 12.01 |
Note:
- The Pre IPO EPS is calculated based on Pre issue shareholding as on the date of RHP and the latest FY earnings as of March 31, 2025, that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of July 31, 202,5 that is available in RHP.
Objects of the Issue (Curis Lifesciences Limited IPO Objectives)
Curis Lifesciences Limited Contact Details
Curis Lifesciences Ltd. PF-23, GIDC Sanand - II, Industrial Estate, Sanand Ahmedabad, Gujarat, 382110 Phone: +91 99045 22543 Email: [email protected] Website: https://curisls.com/ |
Curis Lifesciences Limited IPO Registrar
MUFG Intime India Pvt.Ltd. Phone: +91-22-4918 6270 Email: [email protected] Website: https://linkintime.co.in/Initial_Offer/public-issues.html |